Comparison of Symptoms and Lung Function in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Monobronchodilators and Dual Bronchodilators
Authors
Abstract
Introduction: In COPD treatment with a monobronchodilator or dualbronchodilator, can be assessed for the prognosis of therapy outcomes provided to monitor the impact of intervention and recovery of daily activities, prevent acute exacerbations, and improve the productivity of patient’s COPD. To determine the comparison between symptoms and lung function in patients with COPD disease receiving monobronchodilator and dual bronchodilator.
Method: This study is a retrospective cohort study. The research sample consists of COPD patients undergoing treatment with monobronchodilator or dualbronchodilator for a minimum of 3 months or 3 treatment visits. Symptoms are measured using mMRC and lung function is measured using spirometry (FEV1).
Results: The majority of patients are male (87.1%) and over 60 years old (62.4%), with the majority being smokers (84.7%), and the most common therapy being monobronchodilator (62.4%) and dual bronchodilator (37,6%). There are differences in symptoms and lung function in patients receiving monobronchodilator and dual bronchodilator.
Conclusion: The dual bronchodilator is more effective in reducing mMRC values, improving by 96.3%, and increasing spirometry values. The average FEV1 value in spirometry for patients using the dualbronchodilator increased by 13,907%, while for the monobronchodilator, it decreased by 5.589%.
Similar Articles
- Tasrif Hamdi, What is the function of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in pain processes? , Journal of Society Medicine: Vol. 2 No. 2 (2023): February
- Fadli Ilhami, Ali Nafiah Nasution, Cut Aryfa Andra, Prognostic Value of Tricuspid Annular Plane Systolic Excursion (TAPSE), Right Ventricular Fractional Area Changes (RV FAC) and Pulses Tissue Doppler S' Wave (PTD S') at 30 Days after Care of Acute Miocardial Infarction Patients in Haji Adam Malik Hospital , Journal of Society Medicine: Vol. 2 No. 5 (2023): May
- Monica Tampubolon, Kiki M. Iqbal, R. A. Dwi Pujiastuti, Osmolarity Changes after Mannitol Administration in Cerebral Edema Patients , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
- Mufti Muhammad, Netty DL, Chairil AB, Relationship between Hypertension and Aorta Arch Calcification on Chest X-Ray Photos of Ischemic Stroke Patients at The General Hospital Haji Adam Malik Medan 2022 , Journal of Society Medicine: Vol. 2 No. 9 (2023): September
- Romi Ridwan, Ezra Oktaliansyah, Case Series of Guillain Barre Syndrome with Plasmaparesis in The ICU Bandung Hospital , Journal of Society Medicine: Vol. 3 No. 4 (2024): April
- Billi, Muhammad Akbar, David Gunawan Umbas, Firdaus Hamid, Andi Kurnia Bintang, Mimi Lotisna, Estimated Glomerular Filtration Rate (eGFR) as a Predictor of 1-Month Clinical Outcome in First-Ever Acute Ischemic Stroke Patients , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
- Cut Putri Hazlianda, Ika Diamanda, Current Pathogenesis and Treatment of Cutaneous Lupus Erythematosus , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
- Rikki Oktrian Putra, Yudhisman Imran, Mulia Rahmansyah, Triasti Khusfiani, Mustika Anggiane Putri, Ainaya Az zahra, Case Report of Management of Increased Intracranial Pressure in Epidural Hematoma , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- Adityo Prabowo, Use of Chest X-Ray (CXR) in Covid-19 Screening as A Modalities , Journal of Society Medicine: Vol. 1 No. 2 (2022): November
You may also start an advanced similarity search for this article.